Handling Editor: Daniel Billadeau
ABSTRACT
Survivin (also known as BIRC5) is a cancer-associated protein that is pivotal for cellular life and death – it is an essential mitotic protein and an inhibitor of apoptosis. In cancer cells, a small pool of survivin localises to the mitochondria, the function of which remains to be elucidated. Here, we report that mitochondrial survivin inhibits the selective form of autophagy called ‘mitophagy’, causing an accumulation of respiratory-defective mitochondria. Mechanistically, the data reveal that survivin prevents recruitment of the E3-ubiquitin ligase Parkin to mitochondria and their subsequent recognition by the autophagosome. The data also demonstrate that cells in which mitophagy has been blocked by survivin expression have an increased dependency on glycolysis. As these effects were found exclusively in cancer cells, they suggest that the primary act of mitochondrial survivin is to steer cells towards the implementation of the Warburg transition by inhibiting mitochondrial turnover, which enables them to adapt and survive.
This article has an associated First Person interview with the first author of the paper.
Footnotes
Competing interests
The authors declare no competing or financial interests.
Author contributions
Conceptualization: A.R.T., S.P.W.; Methodology: A.R.T., S.P.W.; Validation: A.R.T., S.P.W.; Investigation: S.P.W.; Data curation: A.R.T.; Writing - original draft: A.R.T.; Writing - review & editing: S.P.W.; Visualization: A.R.T., S.P.W.; Supervision: S.P.W.; Project administration: S.P.W.; Funding acquisition: S.P.W.
Funding
A.R.T. was supported by a Biotechnology and Biological Sciences Research Council studentship.
Supplementary information
Supplementary information available online at https://jcs.biologists.org/lookup/doi/10.1242/jcs.247379.supplemental
- Received April 21, 2020.
- Accepted September 29, 2020.
- © 2020. Published by The Company of Biologists Ltd
Log in using your username and password
Log in through your institution
Pay Per Article - You may access this article (from the computer you are currently using) for 1 day for US$30.00 .
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.
Article navigation
Related articles
Cited by...
More in this TOC section
Similar articles
Subject collections
Other journals from The Company of Biologists
Sustainable Conferencing with The Company of Biologists
A new initiative spearheaded by Directors Sally Lowell, Kate Storey, Alastair Downey and Holly Shiels will provide information, technology and grants to help the community run conferences in a more sustainable way.
FocalPlane image competition 2020 winner – ‘Owl Eyes’
Tejeshwar Rao won FocalPlane’s first image competition with this stunning image 'Owl Eyes'. Find out more over on FocalPlane.
Love your lipids!
Editor-in-Chief Michael Way discusses all things lipids in a new Editorial that introduces the journal’s sixth special issue, Cell Biology of Lipids. We are now welcoming submissions until 15 July 2021.
An interview with Ian Chambers
Winner of the BSCB’s 2020 Hooke medal, Ian Chambers is the Head of the Institute for Stem Cell Research at University of Edinburgh. In an interview, he talks about his research, the effect of COVID-19 on his lab and the future of scientific conferences.
preLights - can the nucleus of a cell move in the absence of dynamic microtubules?
preLighter Leeba Ann Chacko discusses Ashraf et al.’s preprint, which uncovers microtubule-independent nuclear movement in fission yeast cells.
JCS and COVID-19
For more information on measures Journal of Cell Science is taking to support the community during the COVID-19 pandemic, please see here.
If you have any questions or concerns, please do not hestiate to contact the Editorial Office.